3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Ovarian Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Glioblastoma
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Interventions
Gemcitabine
8
Cisplatin
8
pembrolizumab
4
durvalumab
4
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
tivozanib
1
peposertib
1
guadecitabine
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
avelumab
1
atezolizumab
1
Trastuzumab
1
Radiation Dose Hypofractionation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Disulfides
×
90 days
×
Clear all
No trials found.